Value-based care models create powerful incentives to leverage pharmacists at the top of their license — but most organizations are only beginning to capitalize on this opportunity. This session explores where scope expansion is generating the greatest clinical and financial returns, including transitions of care, chronic disease management and quality metric performance. Leaders share the contracting structures and workflows enabling success.